Related Experiment Video

Updated: Nov 3, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.8K

[Development of novel treatment strategies for drug resistant cancer]

Flóra Vajda1, Eszter Bajtai1, Balázs Gombos1

  • 1Természettudományi Kutatóközpont, Eötvös Loránd Kutatási Hálózat, Enzimológiai Intézet, Budapest, Hungary. furedi.andras@ttk.hu.

Magyar Onkologia
|June 3, 2021
PubMed

Insights

Cancer therapy resistance remains a major challenge. This review explores resistance mechanisms and new therapeutic strategies to overcome treatment failure in multidrug resistant cancer.

Area of Science:

  • Oncology
  • Cancer Research
  • Pharmacology

Background:

  • Cancer affects millions globally, with significant mortality despite advances.
  • Current cancer therapies often fail due to the development of resistance.
  • Therapy resistance is a critical obstacle in oncology.

Purpose of the Study:

  • To review key mechanisms of anticancer therapy resistance.
  • To discuss progress in therapies aimed at overcoming resistance.
  • To present novel experimental models and therapeutic approaches for multidrug resistant cancer.

Main Methods:

  • Literature review of cancer therapy resistance mechanisms.
  • Analysis of current and emerging therapeutic strategies.
  • Presentation of original research on new experimental models and treatments.

Main Results:

  • Identification and discussion of major cancer therapy resistance mechanisms.
  • Overview of strategies to prevent or overcome resistance.
  • Introduction of new experimental models and therapeutic approaches for resistant cancers.

Conclusions:

  • Therapy resistance is a central challenge in cancer treatment.
  • Continued research into resistance mechanisms and novel therapies is crucial.
  • Development of new models and treatments holds promise for combating multidrug resistant cancer.

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.4K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.9K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
595
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
797